CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-26 | PAPA JOSEPH C CHAIRMAN & CEO | Grant or award · Non-qualified Stock Options (right To Purchase) | +341,114 | 341,114 | ||
| 2020-02-26 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Grant or award | +13,506 | 84,301 | ||
| 2020-02-26 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Grant or award · Non-qualified Stock Options (right To Purchase) | +56,858 | 56,858 | ||
| 2020-02-26 | Humphries William D. President, Ortho-Dermatologics | Grant or award | +13,506 | 247,533 | ||
| 2020-02-26 | Humphries William D. President, Ortho-Dermatologics | Grant or award · Non-qualified Stock Options (right To Purchase) | +56,858 | 56,858 | ||
| 2020-02-26 | Herendeen Paul EVP and CFO | Grant or award | +63,030 | 316,748 | ||
| 2020-02-26 | Herendeen Paul EVP and CFO | Grant or award · Non-qualified Stock Options (right To Purchase) | +159,192 | 159,192 | ||
| 2020-02-26 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award | +6,753 | 83,670 | ||
| 2020-02-26 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award · Non-qualified Stock Options (right To Purchase) | +28,429 | 28,429 | ||
| 2020-02-26 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Grant or award | +19,449 | 192,165 | ||
| 2020-02-26 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Grant or award · Non-qualified Stock Options (right To Purchase) | +81,873 | 81,873 | ||
| 2020-02-26 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award | +19,449 | 94,367 | ||
| 2020-02-26 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award · Non-qualified Stock Options (right To Purchase) | +81,873 | 81,873 | ||
| 2020-02-20 | Humphries William D. President, Ortho-Dermatologics | Shares withheld for taxes | −56,532 | $26.46 | $1.5M | 234,027 |
| 2020-02-20 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −11,703 | $26.46 | $310K | 70,795 |
| 2020-02-20 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Shares withheld for taxes | −8,943 | $26.46 | $237K | 76,917 |
| 2020-02-20 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Shares withheld for taxes | −9,866 | $26.46 | $261K | 172,716 |
| 2020-02-20 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Shares withheld for taxes | −22,378 | $26.46 | $592K | 59,190 |
| 2020-02-19 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +7,864 | 55,029 | ||
| 2020-02-19 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Restricted Share Units | −7,864 | 0 |
Page 28 of 31 · 608 trades